| 摘要 |
Disclosed is a pharmaceutical formulation of taxane to be administered to mammals, preferable humans, comprising two compositions which are combined prior to being administered, forming a transparent solution free from precipitates wherein: a. the first of said compositions is a solid composition of lyophilised taxane, free from tensoactives and obtained by lyophilisation in a solution comprising a lyophilisation organic solvent and a taxane and, b. the second of said compositions is a solubilising composition of said solid composition of lyophilised taxane that comprises at least one tensoactive. |
